Review
The varied clinical presentations of major depressive disorder
Affiliations
- PMID: 17640152
Item in Clipboard
Review
The varied clinical presentations of major depressive disorder
J Clin Psychiatry.
2007.
Abstract
DSM-IV major depressive disorder (MDD) is a clinical syndrome notable for heterogeneity of its clinical presentation, genetics, neurobiology, clinical course, and treatment responsiveness. In an attempt to make sense of this heterogeneity, clinicians and researchers have proposed a number of MDD "subtypes" based on differences in characteristic symptoms (e.g., atypical, melancholic, psychotic), onset (e.g., early vs. late, post-partum, seasonal), course of illness (e.g., single vs. recurrent, chronic, double), and severity. This article provides a brief review of the status of several of the most common subtypes in terms of their clinical features, biological correlates, course of illness, and treatment implications.
Similar articles
-
Continuous distribution of atypical depressive symptoms between major depressive and bipolar II disorders: dose-response relationship with bipolar family history.Psychopathology. 2008;41(1):39-42. doi: 10.1159/000109954. Epub 2007 Oct 18. Psychopathology. 2008. PMID: 17952020 Review.
-
Does hypomania distinguish bipolar II disorder from major depressive disorder?Psychother Psychosom. 2009;78(1):55-8. doi: 10.1159/000172621. Epub 2008 Nov 18. Psychother Psychosom. 2009. PMID: 19018158
-
How best to identify a bipolar-related subtype among major depressive patients without spontaneous hypomania: superiority of age at onset criterion over recurrence and polarity?J Affect Disord. 2008 Apr;107(1-3):77-88. doi: 10.1016/j.jad.2007.07.032. Epub 2007 Sep 12. J Affect Disord. 2008. PMID: 17854907
-
Fear of harm, a possible phenotype of pediatric bipolar disorder: a dimensional approach to diagnosis for genotyping psychiatric syndromes.J Affect Disord. 2009 Nov;118(1-3):28-38. doi: 10.1016/j.jad.2009.06.016. Epub 2009 Jul 23. J Affect Disord. 2009. PMID: 19631388
-
Late paraphrenia.Psychiatr Clin North Am. 1995 Jun;18(2):335-43. Psychiatr Clin North Am. 1995. PMID: 7659602 Review.
Cited by
-
Neuroimaging Genomics a Predictor of Major Depressive Disorder (MDD).Mol Neurobiol. 2024 Jun;61(6):3427-3440. doi: 10.1007/s12035-023-03775-0. Epub 2023 Nov 22. Mol Neurobiol. 2024. PMID: 37989980 Review.
-
Adaptation of Lipid Profiling in Depression Disease and Treatment: A Critical Review.Int J Mol Sci. 2022 Feb 12;23(4):2032. doi: 10.3390/ijms23042032. Int J Mol Sci. 2022. PMID: 35216147 Free PMC article. Review.
-
From synapse to nucleus: novel targets for treating depression.Neuropharmacology. 2010 Mar-Apr;58(4-5):683-93. doi: 10.1016/j.neuropharm.2009.12.004. Epub 2009 Dec 17. Neuropharmacology. 2010. PMID: 20018197 Free PMC article. Review.
-
Mood-Reactive Self-Esteem and Depression Vulnerability: Person-Specific Symptom Dynamics via Smart Phone Assessment.PLoS One. 2015 Jul 1;10(7):e0129774. doi: 10.1371/journal.pone.0129774. eCollection 2015. PLoS One. 2015. PMID: 26131724 Free PMC article.
-
Treatment response classes in major depressive disorder identified by model-based clustering and validated by clinical prediction models.Transl Psychiatry. 2019 Aug 5;9(1):187. doi: 10.1038/s41398-019-0524-4. Transl Psychiatry. 2019. PMID: 31383853 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
